018092773

BAIT

---

July 9, 2019

Trademark Summary

The trademark application BAIT was filed by Bait Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on August 15, 2019, and still open for oppositions.

The application was filed in English (German was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Pharmaceuticals
  2. Pharmaceutical preparations
  3. Therapeutic pharmaceuticals for the treatment of autoimmune disease and cancer
  4. Pharmaceutical therapeutic agents for medical use
  5. Cell therapy products for the treatment of autoimmune disease and cancer
  6. Cells for medical use
  7. Living cells for medical use
  8. Therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease and cancer
  9. Cell therapy products, namely, genetically engineered immune cells for the treatment of autoimmune disease and cancer
  10. Cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease and cancer
  11. Antibodies
  12. Antibody receptors
  13. Antigens
  14. Antigen receptors
  15. Diagnostic agents, preparations and substances for medical purposes
  16. Pharmaceutical products, namely, diagnostic reagents for medical purposes
  17. Control reagents for medical laboratory purposes
  18. Control reagents for clinical medical purposes.
• The mark was filed in class 42 with following description of goods:
  
  1. Scientific and technological services and research and design relating thereto
  2. Industrial analysis and research services
  3. Research, development, testing and evaluation of pharmaceuticals, pharmaceutical preparations and pharmaceutical therapeutic agents
  4. Research, development, testing and evaluation of medical preparations, cells for medical use, antibodies, antibody receptors, antigens and antigen receptors
  5. Medical and scientific research and development in the field of diagnosis and treatment of autoimmune disease and cancer
  6. Research, development, testing and evaluation of diagnostic agents, preparations and substances for medical purposes
  7. Information, advice and consultancy regarding the aforementioned services.
• The mark was filed in class 44 with following description of goods:
  
  1. Medical services
  2. Medical information services
  3. Medical testing services
  4. Medical diagnostic testing services
  5. Medical treatment services
  6. Medical services for the diagnosis and treatment of autoimmune disease and cancer
  7. Medical services, namely, cell based therapies
  8. Information, advice and consultancy regarding the aforementioned services.